About Purenum
Purenum is a Healthcare company based in Bremen (Germany) founded in 2017, and was acquired by FARCO-PHARMA in June 2023. It operates as a biocompatible adhesives for kidney stone fragment removal are developed. It operates in the Healthcare and Chemicals & Materials sectors. Its chief executive is Manfred Peschka. Purenum offers products and services including mediNiK Hydrogel. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices. Its legal entity is Purenum GmbH. Its competitors include Adhezion Biomedical, RadiSurf, Inno Therapy, HyperBranch Medical and BRIJ Medical and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Purenum was established in 2017 as a spin-off from Fraunhofer-IFAM, based in Bremen, Germany. Biocompatible adhesives tailored for medical procedures are developed by the company within the biotechnology sector. These adhesives facilitate the bonding and extraction of kidney stone fragments post-lithotripsy. Operations center on advancing adhesive technologies for clinical applications, supporting minimally invasive treatments in urology.
- Headquarters Bremen, Germany
- Stage Acquired
- SectorsHealthcareChemicals & Materials
- Phone•••• ••••
- Website purenum.com
- Social LinkedIn
- Acquired by FARCO-PHARMA (Jun 2023)
- Legal Name Purenum Gmbh
- InvestorsBAB - Bremer Aufbau-Bank
& 2 more
- Acquired byFARCO-PHARMA
(Jun 2023)
Products & Services of Purenum
Purenum offers a comprehensive portfolio of products and services, including mediNiK Hydrogel.
Encapsulates kidney stone fragments for removal during procedures.
Funding Insights of Purenum
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Purenum with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Purenum
Purenum has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include BAB - Bremer Aufbau-Bank, High-Tech Gründerfonds and FARCO-PHARMA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in high-tech startups by HTGF. | – | htgf.de | Bonn, Germany | |
Banking regulations are overseen by BAB in Germany. | 2001 | bab-bremen.de | Bremen, Germany | |
Develops and distributes sterile gels and instillation therapies for urology. | 1964 | farco.de | Cologne, Germany |
Investor details for Purenum
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Purenum
1 people are tracked at Purenum (1 in leadership).
| Name | Role | Group |
|---|---|---|
Manfred Peschka | CEO | Leadership |
Complete people profiles for Purenum
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Purenum
3 dated milestones of Purenum across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Purenum is founded.
- Funding First funding round.
- Exit Acquired by FARCO-PHARMA.
Competitors of Purenum
Purenum has 9 listed competitors in our database, 8 of them funded. They include Adhezion Biomedical, RadiSurf, Inno Therapy, HyperBranch Medical and BRIJ Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| adhezion.com | 2001 | Wyomissing, United States | $10.14M | 39 | Developer of cyanoacrylate based surgical, wound management, and infection prevention products | |
| radisurf.com | 2015 | Risskov, Denmark | $3.99M | 18 | Nano adhesive systems for bonding plastics to metals are developed. | |
| innotherapy.com | 2010 | Seoul, South Korea | $2.77M | – | Hemostatic polymers are produced for surgical and wound care applications. | |
| hyperbranch.com | 2003 | Durham, United States | $18.69M | – | Biosurgical devices are developed using proprietary polymers and hydrogels. | |
| brijmedical.com | 2016 | Marietta, United States | $6.78M | – | Medical devices for post-surgical and trauma incision care are provided. | |
| suturegard.com | 2015 | Portland, United States | $580,000 | – | Wound closure devices for skin are manufactured by Suturegard. | |
| musselpolymers.com | 2019 | Bethlehem, United States | $500,000 | – | Adhesive solutions are manufactured for diverse materials and applications. | |
| nvirovate.com | 2021 | Seattle, United States | $750,000 | – | Provider of bio adhesives from soy oil | |
| borayer.com | 2020 | Nanchang, China | – | – | Biomaterials for surgery and wound repair are developed. |
Detailed competitors of Purenum
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Wound Care
10 companies that operate in the same segment as Purenum (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Purenum
Purenum was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Purenum is headquartered in Bremen, Germany. It is registered at Bremen, Bremen, Germany.
Manfred Peschka is the current CEO of Purenum.
Purenum was established in 2017 as a spin-off from Fraunhofer-IFAM, based in Bremen, Germany. Biocompatible adhesives tailored for medical procedures are developed by the company within the biotechnology sector. These adhesives facilitate the bonding and extraction of kidney stone fragments post-lithotripsy. Operations center on advancing adhesive technologies for clinical applications, supporting minimally invasive treatments in urology.
Purenum's top competitors include Adhezion Biomedical, BRIJ Medical and RadiSurf.
Purenum offers mediNiK Hydrogel.
Purenum has 3 investors. Key investors include BAB - Bremer Aufbau-Bank, High-Tech Gründerfonds, and FARCO-PHARMA.
Purenum operates through Purenum Gmbh.
Yes. Purenum was acquired by FARCO-PHARMA in June 2023.